The Nomination and Remuneration Committee at its meeting held on November 13, 2025 hasconsidered and approved the grant of 21,000 stock options to its eligible employees, in terms of the Company s ESOP Scheme- 2022.
GENESYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genesys International's Nomination and Remuneration Committee, at its meeting on November 13, 2025, approved the grant of 21,000 stock options to eligible employees under the company's ESOP Scheme-2022. The grant size is relatively small and is part of the company's existing employee stock incentive plan. No specific exercise price or vesting terms were disclosed in this filing. This is a routine corporate action tied to employee compensation and retention.
This is a small ESOP grant that will lead to minor dilution for existing shareholders. The size is modest enough that it should not materially affect earnings per share or shareholder value, and is a standard employee retention/incentive measure.